Publications
5808 Results
- Journal / Conference
- Haematologica 97(9):1401-1404
- Year
- 2012
- Research Committee(s)
- Leukemia
- PMID
- PMID22315487
- PMC
- PMCID3436242
- Study Number(s)
- S0106, SWOG-8600, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918
Impact of body-mass index in the outcome of adult patients with acute myeloid leukemia
- Journal / Conference
- Journal of Clinical Oncology 30(10):1107-1113;
- Year
- 2012
- Research Committee(s)
- Genitourinary
- PMID
- PMID22370319
- PMC
- PMC3341152
- Study Number(s)
- 30987
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine (PCG) and gemcitabine/cisplatin (GC) in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987
- Journal / Conference
- Clinical Cancer Research 18(15):4004-4012
- Year
- 2012
- Research Committee(s)
- Lung
- PMID
- PMID:22592956
- PMC
- PMC3409929
- Study Number(s)
- S0819
Design of a phase III clinical trial with prospective biomarker validation: SWOG S0819
- Journal / Conference
- Journal of the National Cancer Institute 104(2):159-162
- Year
- 2012
- Research Committee(s)
- Breast
- Study Number(s)
- N9831
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria [PMID22138096; PMC3260130]
- Journal / Conference
- Blood 119(13):3003-3015
- Year
- 2012
- Research Committee(s)
- Myeloma
- PMID
- PMID22271445
- PMC
- PMC3321864
IMWG consensus on maintenance therapy in multiple myeloma
- Journal / Conference
- Clinical Cancer Research 18(1):256-2662
- Year
- 2012
- Research Committee(s)
- Multiple sites and Outcomes and Comparative Effectiveness
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. cooperative group trials
- Journal / Conference
- Blood 120(19):3898-3905;
- Year
- 2012
- Research Committee(s)
- Leukemia
- PMID
- PMID22915637
- PMC
- PMC3496952
- Study Number(s)
- S0325
A randomized trial of dasatinib 100 mg vs imatinib 400 mg in newly diagnosed chronic phase chronic myeloid leukemia
- Journal / Conference
- Clinical Cancer Research 18(3):890-900
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- C89803
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from the intergroup trial CALBG 89803 [PMID22147942; PMC3271172]; https://www.ncbi.nlm.nih.gov/pubmed/22147942
- Journal / Conference
- Lancet 379(9814):432-444
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- PMID22152853
- PMC
- PMC3273723
- Study Number(s)
- SWOG-8814
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials
- Journal / Conference
- Journal of the National Cancer Institute 104(20):1534-1541;
- Year
- 2012
- Research Committee(s)
- Multiple sites
- PMID
- PMID22927506
- PMC
- PMC3708548